Roberto is an investor in the biotech space, with +15 years of investing experience spanning from early stage to private equity deals across multiple geographies.
He serves on the Board of multiple life-science companies throughout Europe and the US, including Vasopharm GmbH (Germany, traumatic brain injury), GNS Healthcare (Cambridge, digital health), Medinet (UK, outsourcing services).
Roberto was a member of 3i’s Private Equity team in London and Milan, investing across sectors but with a particular focus on healthcare. He was previously based in New York with the international merchant bank Greenhill & Co.
Roberto graduated cum laude from Università Bocconi (Milan, Italy) and holds an MBA with honors from The Wharton School of the University of Pennsylvania.
